Pacira divests iovera business to Zimmer Biomet for up to $140M

Pacira BioSciences, Inc.

Upfront payment of $70M; potential milestone payments up to $70M through 2031.
66 employees (~8% of workforce) expected to be hired by Zimmer Biomet at close.
Pacira to use net proceeds to pay down senior secured revolving credit facility.
Parties to collaborate on advancing spasticity program; incremental compensation possible.
Transaction expected to close in Q3 2026, subject to customary conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.